Verastem, Inc. (NASDAQ:VSTM)

CAPS Rating: 4 out of 5

Results 1 - 7 of 7

Recs

0
Member Avatar clangmead (58.81) Submitted: 2/11/2016 9:38:59 AM : Outperform Start Price: $1.13 VSTM Score: +24.30

mpor1

Recs

1
Member Avatar PrototypeZ (26.98) Submitted: 1/6/2016 11:34:59 AM : Outperform Start Price: $10.22 VSTM Score: -84.77

Bio lemming pick zz

Recs

0
Member Avatar oscillation (38.53) Submitted: 12/20/2015 2:48:48 AM : Outperform Start Price: $1.75 VSTM Score: -14.11

nev

Recs

0
Member Avatar Haugurafpeningum (26.68) Submitted: 5/4/2015 7:07:17 AM : Outperform Start Price: $8.58 VSTM Score: -80.27

Insider Monkey. Improving OBV

Recs

0
Member Avatar akamaidude (< 20) Submitted: 1/10/2014 10:09:15 PM : Outperform Start Price: $13.57 VSTM Score: -101.71

Promising technology and approach for cancer treatment and cure.

Recs

0
Member Avatar rknapton (64.80) Submitted: 8/22/2013 5:22:16 PM : Underperform Start Price: $14.67 VSTM Score: +114.24

Short. No revenues… if gets some might change to neutral.

Recs

0
Member Avatar cowman1 (< 20) Submitted: 1/24/2013 4:26:15 PM : Outperform Start Price: $10.21 VSTM Score: -123.48

USB analyst Matthew Roden thinks the company has a formular likely to prove crucial in the fight against many types of cancer.

Results 1 - 7 of 7

Featured Broker Partners